Protein Eating Patterns and Weight Loss
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03202069 |
Recruitment Status :
Completed
First Posted : June 28, 2017
Last Update Posted : November 2, 2023
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Obesity | Other: Even protein Other: Skewed protein | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 45 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Other |
Official Title: | Effect of Daily Protein Intake Patterns During Weight Loss on Dietary Adherence and Body Composition in Women |
Actual Study Start Date : | October 2, 2017 |
Actual Primary Completion Date : | April 14, 2023 |
Actual Study Completion Date : | April 14, 2023 |
Arm | Intervention/treatment |
---|---|
Experimental: Even protein intake
Menu to provide 90 g of protein per day in an even distribution of 30 g at each meal.
|
Other: Even protein
Intake of even protein 5 day rotating menu |
Experimental: Skewed protein intake
Menu to provide 90 g of protein per day in a skewed distribution of 10 g at breakfast, 15 g at lunch and 65 g at dinner.
|
Other: Skewed protein
Intake of skewed protein 5 day rotating menu |
- Body Composition [ Time Frame: 8 and 16 weeks ]Determine the effects of two patterns of daily protein intake on changes in fat mass and fat-free mass during weight loss.
- Diet Adherence [ Time Frame: 16 weeks ]Determine the effects of two patterns of daily protein intake on weight loss diet adherence and putative mediators (satisfaction, satiety, hunger, and reinforcing value of energy dense foods) of adherence.
- Barriers to weight control [ Time Frame: 1 hour ]Nominal Group Technique results providing an exhaustive list of barriers to weight control in overweight and obese women
- Change in skeletal muscle protein breakdown [ Time Frame: 8 and 16 weeks ]The effect of consuming two patterns of daily protein intake on 3-Methylhistidine degradation, a biochemcial marker of skeletal muscle protein breakdown
- Circulating carotenoid levels [ Time Frame: 8 and 16 weeks ]The effect of consuming two patterns of protein intake during weight loss on circulating carotenoid levels.
- Relative reinforcing value (RRV) of food [ Time Frame: 8 and 16 weeks ]The effect of consuming two patterns of daily protein intake during weight loss on the RRV of energy-dense snack food
- Change in bone turnover [ Time Frame: 8 and 16 weeks ]The effect of consuming two patterns of daily protein intake during weight loss on osteocalcin, alkaline phosphatase, acid phosphatase, and collagen cross-link molecules -- biochemical markers of bone formation and resorption
- Plasma lipids [ Time Frame: 8 and 16 weeks ]The effect of consuming two patterns of daily protein intake during weight loss on lipid and triglyceride molecular speciation.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 20 Years to 44 Years (Adult) |
Sexes Eligible for Study: | Female |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- BMI 28-45 kg/m2
Exclusion Criteria:
- unable or unwilling to consume animal products
- unable or unwilling to attend treatment group meetings
- had more than a 10% change in body weight in the 2 months prior to study start date
- consuming a specialized diet
- have a history of and eating or gastrointestinal disorder
- currently or planning on becoming pregnant during the study timeline
- lactating
- have an uncontrolled metabolic illness/disease (fasting glucose >125 mg/dL)
- have uncontrolled hypertension (>160/99 mm Hg)
- have cancer or in short-term remission (less than 3 years)
- have an infectious disease
- suffer from alcohol or drug abuse
- use tobacco and/or e-cigarette products on a regular basis
- taking medications known to affect energy expenditure and appetite
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03202069
United States, North Dakota | |
USDA Grand Forks Human Nutrition Research Center | |
Grand Forks, North Dakota, United States, 58203 |
Principal Investigator: | Shanon Casperson, PhD | USDA Grand Forks Human Nutrition Research Center |
Documents provided by Shanon Casperson, USDA Grand Forks Human Nutrition Research Center:
Responsible Party: | Shanon Casperson, PhD, USDA Grand Forks Human Nutrition Research Center |
ClinicalTrials.gov Identifier: | NCT03202069 |
Other Study ID Numbers: |
GFHNRC510 |
First Posted: | June 28, 2017 Key Record Dates |
Last Update Posted: | November 2, 2023 |
Last Verified: | October 2023 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Protein Weight Loss |
Weight Loss Body Weight Changes Body Weight |